Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.

scientific article

Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3499490

P2093author name stringFazekas F
Kushner M
Rosen M
Alavi A
Alavi J
Chawluk J
Reivich M
Tobin M
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectglucoseQ37525
P304page(s)1667-1670
P577publication date1987-11-01
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476titleCerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
P478volume28

Reverse relations

cites work (P2860)
Q53297279A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
Q47144813A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults
Q44795484Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
Q35193335Association between functional connectivity hubs and brain networks
Q33855135Cerebral glucose metabolism on positron emission tomography of children
Q48334954Cerebrocerebellar relationships in normal subjects and patients with dementia of the Alzheimer type: a SPECT study
Q70259351Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia
Q36314634Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography
Q50629638Dynamic brain glucose metabolism identifies anti-correlated cortical-cerebellar networks at rest.
Q34313509Electrophysiological monitoring of injury progression in the rat cerebellar cortex
Q46602955Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample
Q48419621Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction
Q48609636Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective
Q53311097Neuropsychological tests and [99mTc]-HM PAO SPECT in the diagnosis of Alzheimer's dementia.
Q43515040New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose
Q48210325Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.
Q37217103Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease
Q42097151Resting-State Metabolism of Hand Knob Area on 18F-FDG PET-CT According to Hand Function and Tractography of Corticospinal Tract After Stroke.
Q30584277The relationship between cerebral glucose metabolism and age: report of a large brain PET data set
Q36433580The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation
Q48678657The time-course of bilateral changes in the reflex excitability of relaxed triceps surae muscle in human hemiparetic spasticity